Showing 881 - 900 results of 53,548 for search '(( 5 ((non decrease) OR (mean decrease)) ) OR ( 50 ((teer decrease) OR (a decrease)) ))', query time: 1.27s Refine Results
  1. 881
  2. 882
  3. 883
  4. 884
  5. 885

    Effect of the universal nuclease on various concentration of infectious intact FCoV viruses. by Finja Rausch (14352176)

    Published 2023
    “…<p>Similar time threshold with or without nuclease was detected (A), however, RT-PCR assay showed a decreased cycle threshold in nuclease pretreated samples, especially samples with lower TCID<sub>50</sub> (B). …”
  6. 886
  7. 887

    Hsa_circ_0017639 regulates cisplatin resistance and tumor growth via acting as a miR-1296-5p molecular sponge and modulating sine oculis homeobox 1 expression in non-small cell lun... by Feiyun Chang (12243382)

    Published 2022
    “…In conclusion, circ_0017639 conferred DDP resistance and promoted tumor growth via elevating SIX1 expression through sequestering miR-1296-5p in NSCLC, providing a new mechanism for understanding the chemoresistance and progression of NSCLC.…”
  8. 888
  9. 889

    Light-emitting diode generated red light (LED-RL) at a fluence of 480 J/cm<sup>2</sup> significantly decreased relative fibroblast migration speed to 83.0±5.6% (p = 0.0393) compare... by Andrew Mamalis (5665591)

    Published 2015
    “…Error bars represent standard error of the mean. (* represents P < .05). Fig 3B. Light-emitting diode generated red light (LED-RL) at a fluence of 640 J/cm<sup>2</sup> significantly decreased relative fibroblast migration speed to 74.4±5.5% (p = 0.0003) compared to matched controls (100±4.2%). …”
  10. 890

    Effects of Pitavastatin on Lipid Profiles in HIV-Infected Patients with Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-Blind, Crossover Study by Asita Wongprikorn (2837378)

    Published 2016
    “…At 12 weeks of treatment with pitavastatin compared to placebo; mean [95% confidence interval (CI)] total cholesterol (TC) was 207 (187.3, 226.8) mg/dL vs 246.3 (226.5, 266) mg/dL (<i>p</i> <0.001); mean (95% CI) triglyceride (TG) was 351.3 (193.2, 509.4) mg/dL vs 279.1 (121, 437.2) mg/dL (<i>p</i> = 0.269); mean (95% CI) high density lipoprotein (HDL) was 45.3 (40.4, 50.2) mg/dL vs 44.2 (39.3, 49.1) mg/dL (<i>p</i> = 0.354); and mean (95% CI) low density lipoprotein (LDL) was 113.2 (100.4, 126) mg/dL vs 145.6 (132.8, 158.4) mg/dL (<i>p</i> <0.001). …”
  11. 891
  12. 892

    S1 Data - by Phu Dinh Vu (19429477)

    Published 2024
    Subjects:
  13. 893
  14. 894
  15. 895
  16. 896
  17. 897

    A functional PSA mimetic peptide (fPSA) prevents glutamate-induced MAP-2 decrease and concomitant changes in SYN and NCAM synaptic patterns and levels. by María Fernanda Podestá (639243)

    Published 2014
    “…(B) Quantification of MAP-2 immunoreactive area showed decreased levels 6 h after glutamate exposure; this decrease was prevented by fPSA. …”
  18. 898
  19. 899
  20. 900